Risk stratification in patients with pulmonary arterial hypertension (PAH) and candidates for lung or heart-lung transplantation

H. Vicaire (Le Kremlin-Bicêtre, France), J. Le Pavec (Le Plessis Robinson, France), A. Boucly (Le Kremlin-Bicêtre, France), X. Jais (Le Kremlin-Bicêtre, France), O. Mercier (Le Plessis Robinson, France), D. Montani (Le Kremlin-Bicêtre, France), E. Fadel (Le Plessis Robinson, France), M. Humbert (Le Plessis Robinson, France), O. Sitbon (Le Plessis Robinson, France), L. Savale (Le Kremlin-Bicêtre, France)

Source: Virtual Congress 2021 – All about pulmonary arterial hypertension
Session: All about pulmonary arterial hypertension
Session type: Oral Presentation
Number: 141

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Vicaire (Le Kremlin-Bicêtre, France), J. Le Pavec (Le Plessis Robinson, France), A. Boucly (Le Kremlin-Bicêtre, France), X. Jais (Le Kremlin-Bicêtre, France), O. Mercier (Le Plessis Robinson, France), D. Montani (Le Kremlin-Bicêtre, France), E. Fadel (Le Plessis Robinson, France), M. Humbert (Le Plessis Robinson, France), O. Sitbon (Le Plessis Robinson, France), L. Savale (Le Kremlin-Bicêtre, France). Risk stratification in patients with pulmonary arterial hypertension (PAH) and candidates for lung or heart-lung transplantation. 141

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk stratification in pulmonary arterial hypertension (PAH)
Source: International Congress 2018 – New trends in the management of pulmonary hypertension
Year: 2018


Lung transplantation for pulmonary arterial hypertension
Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results
Year: 2015



Impact of pulmonary hypertension after lung transplantation on functional outcome
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010

The management of patients awaiting lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=16
Year: 2003

Advanced pulmonary arterial hypertension: mechanical support and lung transplantation
Source: Eur Respir Rev, 26 (146) 170089; 10.1183/16000617.0089-2017
Year: 2017



Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012



Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung
Source: Eur Respir J 2003; 21: 192-194
Year: 2003



Lung transplantation for pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 247-255
Year: 2012


Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Assessment of pulmonary hypertension in lung transplantation candidates; correlation of doppler echocardiography with right heart catheterization
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD)
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019



Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007



Prognosis in patients with primary pulmonary hypertension awaiting lung transplantion
Source: Eur Respir J 2001; 18: Suppl. 33, 297s
Year: 2001

Prevalence and echocardiographic screening for pulmonary hypertension in liver transplantation recipients
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


Accuracy of pre-operative specimen level prediction in chronic thromboembolic pulmonary hypertension (CTEPH) patients undergoing pulmonary thromboendarterectomy (PTE)
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Determinants and prognostic value of kidney disease in pulmonary arterial hypertension
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018


Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



Outcome of candidates for liver transplantation suffering from portopulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease in the French PAH registry
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011